Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraception can improve acne and excess hair growth, enhancing women's quality of life.

Women with telogen effluvium have lower levels of VEGF, which may contribute to their hair loss.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Women with PCOS have higher cardiometabolic risks, but these may be reduced.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

PRP injections effectively improve stress urinary incontinence in women.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Many young women have Polycystic Ovarian Syndrome (PCOS), which is often linked with irregular periods, depression, low self-esteem, and insomnia. Lifestyle and diet changes, along with regular counseling, can help manage these symptoms.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Trichoscopy can diagnose hair loss by looking for common signs like uneven hair thickness, "yellow dots," and more thin hairs, which are found in both men and women.

Hair proteomics could be a promising non-invasive way to identify stress-related disorders.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Exercise helps improve symptoms and mental health in women with PCOS.

The trichogram is a practical, non-invasive, and cost-effective tool for diagnosing female androgenetic alopecia.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Hair loss in men and women can be treated with medications and therapies, showing improvement after 6 months.

Hair analysis can help diagnose adrenal disorders non-invasively.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Hyperthyroidism mostly affects young women and can cause heart issues, but these can improve with treatment.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.